Mohamed Mahmoud Issa

Title: The Innovative Contributions of Mohamed Mahmoud Issa

Introduction

Mohamed Mahmoud Issa is a notable inventor based in Uppsala, Sweden. He has made significant contributions to the field of biotechnology, particularly in the development of non-viral delivery systems for oligonucleotides. His work focuses on enhancing the efficiency of gene silencing techniques, which have important implications for medical research and therapeutic applications.

Latest Patents

Issa holds a patent for "Oligonucleotide non-viral delivery systems." This innovative technology utilizes low molecular weight chitosan oligomers that can self-assemble siRNA into nanosized particles. These particles provide protection against enzymatic degradation and facilitate stable gene silencing over extended periods in vitro. The ability to control structural variables in formulating complexes of siRNA with low molecular weight chitosans presents an efficient alternative delivery system for siRNA, both in vitro and in vivo.

Career Highlights

Currently, Mohamed Mahmoud Issa is associated with Fmc Biopolymer AS, where he continues to advance his research in biopolymer applications. His work has garnered attention for its potential to revolutionize gene therapy and improve the delivery of therapeutic agents.

Collaborations

Issa collaborates with esteemed colleagues, including Sabina Prochazkova Strand and Per Artur Sven Artursson. These partnerships enhance the research environment and contribute to the innovative outcomes of their projects.

Conclusion

In summary, Mohamed Mahmoud Issa's contributions to the field of biotechnology through his patented work on oligonucleotide delivery systems highlight his role as a leading inventor. His ongoing research and collaborations promise to further advance the capabilities of gene therapy and biopolymer applications.